PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
Clinical trial NCT03013491 · TERMINATED
Trial details
- NCT number
- NCT03013491
- Sponsor
- CytomX Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2020-10-27
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.